MENU
+Compare
MBXBF
Stock ticker: OTC
AS OF
Nov 18 closing price
Price
$0.18
Change
-$0.00 (-0.00%)
Capitalization
24.06M

MBXBF Microbix Biosystems Inc. Forecast, Technical & Fundamental Analysis

Microbix Biosystems Inc develops biological products and technologies... Show more

MBXBF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for MBXBF with price predictions
Nov 18, 2025

MBXBF in downward trend: 10-day moving average moved below 50-day moving average on November 10, 2025

The 10-day moving average for MBXBF crossed bearishly below the 50-day moving average on November 10, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

MBXBF moved below its 50-day moving average on November 14, 2025 date and that indicates a change from an upward trend to a downward trend.

The Aroon Indicator for MBXBF entered a downward trend on November 18, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 12, 2025. You may want to consider a long position or call options on MBXBF as a result. In of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for MBXBF just turned positive on November 13, 2025. Looking at past instances where MBXBF's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MBXBF advanced for three days, in of 84 cases, the price rose further within the following month. The odds of a continued upward trend are .

MBXBF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. MBXBF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.215) is normal, around the industry mean (23.122). P/E Ratio (22.170) is within average values for comparable stocks, (61.014). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.073). Dividend Yield (0.000) settles around the average of (0.047) among similar stocks. P/S Ratio (1.675) is also within normal values, averaging (332.704).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MBXBF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
MBXBF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
265 Watline Avenue
Phone
+1 905 361-8910
Employees
70
Web
https://www.microbix.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VASO0.14N/A
+1.97%
Vaso Corporation
ANZLY1.70N/A
N/A
Air New Zealand Ltd.
AILIP71.45N/A
N/A
Ameren Illinois Company
NTNOF0.60N/A
N/A
NORTHERN OCEAN LTD
KWHIY26.27-1.31
-4.73%
Kawasaki Heavy Industries Ltd.

MBXBF and Stocks

Correlation & Price change

A.I.dvisor tells us that MBXBF and CRMD have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MBXBF and CRMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBXBF
1D Price
Change %
MBXBF100%
-0.63%
CRMD - MBXBF
27%
Poorly correlated
+0.95%
TECX - MBXBF
23%
Poorly correlated
-0.73%
BVNKF - MBXBF
21%
Poorly correlated
-21.26%
NBY - MBXBF
20%
Poorly correlated
-0.92%
MMIRF - MBXBF
15%
Poorly correlated
N/A
More